Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:46 AM
Ignite Modification Date:
2025-12-25 @ 12:46 AM
NCT ID:
NCT02825667
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with hemophilia A and B
* Adults patients
* Patients with hemophilic arthropathy of ankle diagnosed
* Patients in prophylactic treatment regimen or on demand treatment with concentrates of FVIII/FIX.
Exclusion Criteria:
* Patients without ambulation
* Patients diagnosed with other congenital coagulopathy (eg, Von Willebrand disease)
* Patients who have developed antibodies to FVIII / FIX (inhibitors)
* Patients with neurological or cognitive impairments that prevent understanding of questionnaires and test physical
* Patients that have not signed the informed consent document.
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02825667
Study Brief:
Protocol Section:
NCT02825667